Viking Therapeutics’ new contract is a game changer. Here’s how much money it could bring in.
Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...
Viking Therapeutics: No Buyout Needed Now
Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...
Business Insider2y
How Viking Global became the hedge-fund industry's hottest launch pad
Since Dan Sundheim's massively successful launch of D1 Capital in 2018, there have been six more spinoffs from Viking Global that ... raising over $1 billion. Funds on the way include Divya ...
Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade)
Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...
What we know about Avantyr Capital, the newest Viking Global spinout from its former top investor Ning Jin
Ning Jin has made hires, picked a name for his new firm, and relayed to potential investors that the strategy can take on $1 billion.
Business Insider India5y
Viking's former investment chief is gearing up to launch his own fund in mid-2020 and join the long list of Tiger Management grandcubs
The Tiger family tree continues to grow. Ben Jacobs, Viking Global Investors' former co-chief investment officer, is planning to launch his own fund in New York, which will be named Anomaly ...
Morningstar5d
Viking Therapeutics' new contract is a game changer. Here's how much money it could bring in.
and that's drawing cheers Truist analysts said the news was a "material positive" that moves Viking one step closer to being third to launch a branded GLP-1 drug. Analysts led by Joon Lee ...